版本:
中国

BRIEF-Shire announces update to vyvanse U.S. labeling

Oct 17 Shire PLC

* Shire PLC - Shire announces update to vyvanse (lisdexamfetamine dimesylate) U.S. labeling

* Shire PLC - labeling to include information regarding approval of a supplemental new drug application (SNDA) by U.S. Food and Drug Administration

* Shire PLC - labeling will now include maintenance of efficacy data from SPD489-346 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐